On November 21, 2019, the Patented Medicine Prices Review Board (PMPRB) released draft Guidelines operationalizing the recent amendments to the Patented Medicines Regulations for consultation (see our overview of the draft Guidelines here). The deadline for providing written submissions has been extended from January 20, 2020 to January 31, 2020. The PMPRB began meeting with stakeholders to discuss the new Guidelines in early December.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.